25. Results of pulmonary valve replacement surgery in adults at Hanoi Medical University Hospital
Main Article Content
Abstract
A case series of 6 pulmonary valve replacements with bioprothesis in adults was performed at Hanoi Medical University Hospital from 2021 to 2025. Patients included 5 females and 1 male, with a mean age of 41.5 years old. There was five cases of congenital heart disease with valvular stenosis and one case of severe regurgitation after total repair of tetralogy of Fallot. There was no death or complication requiring further surgical intervention after the valve replacement. All patients improved clinically post surgery, with an average maximum pressure gradient across the bioprosthetic valve on echocardiography of 16.3 ± 5.9mmHg. Pulmonary valve replacement with a bioprosthetic valve is safe with good early results, but further studies are needed to evaluate it over a longer period of time.
Article Details
Keywords
Pulmonary stenosis, pulmonary regurgitation, tetralogy of Fallot, pulmonary valve replacement
References
2. Kang N, Smith W, Greaves S, et al. Pulmonary-Valve Endocarditis. New England Journal of Medicine. 356(21): 2224-2225. doi:10.1056/NEJMc070349.
3. Quintessenza JA, Jacobs JP, Morell VO, et al. Initial Experience With a Bicuspid Polytetrafluoroethylene Pulmonary Valve in 41 Children and Adults: A New Option For Right Ventricular Outflow Tract Reconstruction. The Annals of Thoracic Surgery. 2005/03/01/ 2005; 79(3): 924-931. doi:https://doi.org/10.1016/j.athoracsur.2004.05.045.
4. Rosti L, Murzi B, Colli AM, et al. Mechanical valves in the pulmonary position: A reappraisal. The Journal of Thoracic and Cardiovascular Surgery. 1998/05/01/ 1998; 115(5): 1074-1079. doi:https://doi.org/10.1016/S0022-5223(98)70407-6.
5. Fiore AC, Rodefeld M, Turrentine M, et al. Pulmonary Valve Replacement: A Comparison of Three Biological Valves. The Annals of Thoracic Surgery. 2008/05/01/ 2008; 85(5): 1712-1718. doi:https://doi.org/10.1016/j.athoracsur.2008.02.001.
6. Dittrich S, Alexi-Meskishvili VV, Yankah AC, et al. Comparison of porcine xenografts and homografts for pulmonary valve replacement in children. The Annals of Thoracic Surgery. 2000/09/01/ 2000; 70(3): 717-722. doi:https://doi.org/10.1016/S0003-4975(00)01532-0.
7. Ilbawi MN, Lockhart CG, Idriss FS, et al. Experience with St. Jude Medical valve prosthesis in children: a word of caution regarding right-sided placement. The Journal of Thoracic and Cardiovascular Surgery. 1987; 93(1): 73-79.
8. Hopkins RA, Louis JS, Corcoran PC. Ross’ first homograft replacement of the aortic valve. The Annals of thoracic surgery. 1991; 52(5): 1190-1193.
9. Cocomello L, Meloni M, Rapetto F, et al. Long-term comparison between pulmonary homograft versus bioprosthesis for pulmonary valve replacement in tetralogy of fallot. Journal of the American Heart Association. 2019; 8(24): e013654.
10. Kotani Y, Kasahara S. Bioprosthetic Pulmonary Valve Replacement. Operative Techniques in Thoracic and Cardiovascular Surgery. 2020; 25(1): 13-26.
11. Bertranou EG, Blackstone EH, Hazelrig JB, et al. Life expectancy without surgery in tetralogy of Fallot. The American journal of cardiology. 1978; 42(3): 458-466.
12. Dittrich S, Vogel M, Dähnert I, et al. Surgical repair of tetralogy of Fallot in adults today. Clinical cardiology. 1999; 22(7): 460-464.
13. Hu DC, Seward JB, Puga FJ, et al. Total correction of tetralogy of Fallot at age 40 years and older: long-term follow-up. Journal of the American College of Cardiology. 1985; 5(1): 40-44.
14. Morton BC, Morch JE, Williams WG. Primary repair of Fallot’s tetralogy in an older adult: a 20-year follow-up. The Canadian journal of cardiology. 1996/12// 1996; 12(12): 1268-1270.
15. Chehri G, Moludi J, Tabaei AS, et al. Health outcomes of on-pump pulmonary valve replacement surgery with and without cardioplegic arrest: a comparison study in tetralogy of Fallot subjects. Am J Cardiovasc Dis. 2019; 9(2): 18-24.
16. Kwak JG, Lee JR, Kim W-H, et al. Mid-term results of the Hancock II valve and Carpentier-Edward Perimount valve in the pulmonary portion in congenital heart disease. Heart, Lung and Circulation. 2010; 19(4): 243-246.
17. Zubairi R, Malik S, Jaquiss RD, et al. Risk factors for prosthesis failure in pulmonary valve replacement. The Annals of thoracic surgery. 2011; 91(2): 561-565.
18. Francis Gary S, Bartos Jason A, Adatya S. Inotropes. JACC. 2014/05/27 2014; 63(20): 2069-2078. doi:10.1016/j.jacc.2014.01.016.
19. Grose R, Strain J, Greenberg M, et al. Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure. Journal of the American College of Cardiology. 1986/05/01/ 1986; 7(5): 1107-1113. doi:https://doi.org/10.1016/S0735-1097(86)80231-5.